Experiment summary for ENCSR000EMY
doi:10.17989/ENCSR000EMY
Summary
- Status
- released
- Assay
- DNase-seq
- Biosample summary
- Homo sapiens cardiac muscle cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 days
- Biosample Type
- in vitro differentiated cells
- Replication type
- isogenic
- Description
- DNase-seq on human H7-hESC differentiated for 14 days
- Treatments
- 5 ng/mL Fibroblast growth factor 2 (UniProtKB:P09038) for 14 days, 10 ng/mL Bone morphogenetic protein 4 (UniProtKB:P12644) for 14 days, 6 ng/mL Activin A (CHEBI:81351) for 14 days
- Nucleic acid type
- DNA
- Fragmentation methods
- see document
- Platform
- Illumina Genome Analyzer I
Attribution
ENCODE2 project
- Lab
- John Stamatoyannopoulos, UW
- Award
- U54HG004592 (John Stamatoyannopoulos, UW)
- Project
- ENCODE
- External resources
- Date submitted
- January 11, 2011
- Date released
- March 6, 2012
- Treatment Time Series
- ENCSR167QXA
- Reference Epigenome
- ENCSR590OZV
- Annotation (gkmsvm-model)
- Tags
- Registry of cCREs
Encyclopedia Integration
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Library |
|---|---|---|---|---|
| 2 | 1 | Homo sapiens female embryo cardiac muscle in vitro differentiated cells originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 days | ENCBS532SEX | ENCLB447ZZZ |
| 1 | 1 | Homo sapiens female embryo cardiac muscle in vitro differentiated cells originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 days | ENCBS294AAA | ENCLB448ZZZ |